Variant · Snv
TRMT5 NM_020810.3(TRMT5):c.11+19T>G
CI-VAR-00233939Explore in graph →NM_020810.3:c.11+19T>GClinVar 1601248 rs35851133
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1601248 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Gastric cancer; Ovarian serous cystadenocarcinoma; Uterine carcinosarcoma; Thymoma; Uterine corpus endometrial carcinoma; Uveal melanoma; Clear cell carcinoma of kidney; Sarcoma; Acute myeloid leukemia | germline | 3 | Feb 04, 2026 | clinvar |